Related references
Note: Only part of the references are listed.PNPLA3 gene polymorphism and response to lifestyle modification in patients with nonalcoholic fatty liver disease
Jiayun Shen et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2015)
Cardiovascular pleiotropic actions of DPP-4 inhibitors: A step at the cutting edge in understanding their additional therapeutic potentials
Pitchai Balakumar et al.
CELLULAR SIGNALLING (2013)
Role of Patatin-Like Phospholipase Domain-Containing 3 on Lipid-Induced Hepatic Steatosis and Insulin Resistance in Rats
Naoki Kumashiro et al.
HEPATOLOGY (2013)
Role of Obesity and Lipotoxicity in the Development of Nonalcoholic Steatohepatitis: Pathophysiology and Clinical Implications
Kenneth Cusi
GASTROENTEROLOGY (2012)
Diet-Induced Adipose Tissue Inflammation and Liver Steatosis Are Prevented by DPP-4 Inhibition in Diabetic Mice
Jun Shirakawa et al.
DIABETES (2011)
Preclinical development of dipeptidyl peptidase IV inhibitor alogliptin: a brief overview
Kishore V. L. Parsa et al.
EXPERT OPINION ON DRUG DISCOVERY (2011)
Sitagliptin as a Novel Treatment Agent for Non-Alcoholic Fatty Liver Disease Patients with Type 2 Diabetes Mellitus
Tomoyuki Iwasaki et al.
HEPATO-GASTROENTEROLOGY (2011)
Protective Effects of Dipeptidyl Peptidase-4 (DPP-4) Inhibitor against Increased β Cell Apoptosis Induced by Dietary Sucrose and Linoleic Acid in Mice with Diabetes
Jun Shirakawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in Japan
Takeshi Okanoue et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease
Kikuko Hotta et al.
BMC MEDICAL GENETICS (2010)
Diagnosis and Classification of Diabetes Mellitus
DIABETES CARE (2010)
A Sequence Variation (I148M) in PNPLA3 Associated with Nonalcoholic Fatty Liver Disease Disrupts Triglyceride Hydrolysis
Shaoqing He et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Genome-wide association study of hematological and biochemical traits in a Japanese population
Yoichiro Kamatani et al.
NATURE GENETICS (2010)
Serum Dipeptidyl Peptidase-4 Activity in Insulin Resistant Patients with Non-Alcoholic Fatty Liver Disease: A Novel Liver Disease Biomarker
Gabor Firneisz et al.
PLOS ONE (2010)
Independent Predictors of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
Noreen Hossain et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Long-Term Follow-Up of Patients With Nonalcoholic Fatty Liver
Nila Rafiq et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Population-Based Genome-wide Association Studies Reveal Six Loci Influencing Plasma Levels of Liver Enzymes
Xin Yuan et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2008)
Genes and Nonalcoholic Fatty Liver Disease
Nimantha Mark Wilfred de Alwis et al.
CURRENT DIABETES REPORTS (2008)
Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: A role for insulin resistance and diabetes
Anna Ludovica Fracanzani et al.
HEPATOLOGY (2008)
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Stefano Romeo et al.
NATURE GENETICS (2008)
Obesity and nonalcoholic fatty liver disease
Paul Angulo
NUTRITION REVIEWS (2007)
How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences?
Deepak N. Amarapurkar et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
Polymorphism in microsomal triglyceride transfer protein: A link between liver disease and atherogenic postprandial lipid profile in NASH?
Roberto Gambino et al.
HEPATOLOGY (2007)
Metabolism and excretion of the dipeptidyl peptidase 4 inhibitor [14C]sitagliptin in humans
Stella H. Vincent et al.
DRUG METABOLISM AND DISPOSITION (2007)
Influence of TNF gene polymorphisms in Japanese patients with NASH and simple steatosis
Katsutoshi Tokushige et al.
JOURNAL OF HEPATOLOGY (2007)
Global challenges in liver disease
Roger Williams
HEPATOLOGY (2006)
The metabolic syndrome as a predictor of nonalcoholic fatty liver disease
M Hamaguchi et al.
ANNALS OF INTERNAL MEDICINE (2005)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner et al.
HEPATOLOGY (2005)
Long term prognosis of fatty liver: risk of chronic liver disease and death
S Dam-Larsen et al.
GUT (2004)
Polymorphisms of microsomal triglyceride transfer protein gene and manganese superoxide dismutase gene in non-alcoholic steatohepatitis
C Namikawa et al.
JOURNAL OF HEPATOLOGY (2004)
Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background
S Kojima et al.
JOURNAL OF GASTROENTEROLOGY (2003)
Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference
BA Neuschwander-Tetri et al.
HEPATOLOGY (2003)
Medical progress - Nonalcoholic fatty liver disease
P Angulo
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Nonalcoholic fatty liver disease - A feature of the metabolic syndrome
G Marchesini et al.
DIABETES (2001)
Share Paper
